Cargando…

Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine

Mostrar otras versiones (1)

Malaria, caused by Plasmodium parasites, remains one of the most devastating infectious diseases worldwide, despite control efforts that have lowered morbidity and mortality. The only P. falciparum vaccine candidates to show field efficacy are those targeting the asymptomatic pre-erythrocytic (PE) s...

Descripción completa

Detalles Bibliográficos
Autores principales:	MacMillen, Zachary, Hatzakis, Kiara, Simpson, Adrian, Shears, Melanie, Watson, Felicia, Erasmus, Jesse, Khandhar, Amit, Wilder, Brandon, Murphy, Sean, Reed, Steven, Davie, James, AVRIL, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350175/ https://www.ncbi.nlm.nih.gov/pubmed/37461621 http://dx.doi.org/10.21203/rs.3.rs-3045076/v1

Ejemplares similares

Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine
por: MacMillen, Zachary, et al.
Publicado: (2023)

Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines
por: Lu, Chafen, et al.
Publicado: (2020)

Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
por: Duthie, Malcolm S., et al.
Publicado: (2018)

ReverCSP: Time-Travelling in CSP Computations
por: Galindo, Carlos, et al.
Publicado: (2020)

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018)

Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
por: Tamminga, Cindy, et al.
Publicado: (2011)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

Interrogating the Plasmodium Sporozoite Surface: Identification of Surface-Exposed Proteins and Demonstration of Glycosylation on CSP and TRAP by Mass Spectrometry-Based Proteomics
por: Swearingen, Kristian E., et al.
Publicado: (2016)

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming
por: Sedegah, Martha, et al.
Publicado: (2015)

TnpA(REP) and REP sequences dissemination in bacterial genomes: REP recognition determinants
por: Corneloup, Alix, et al.
Publicado: (2021)

19th Stanford Computer Forum
por: MacMillen, K, et al.
Publicado: (1987)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

Isolation and Characterization of Vaccine Candidate Genes Including CSP and MSP1 in Plasmodium yoelii
por: Kim, Seon-Hee, et al.
Publicado: (2017)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
por: Jelínková, Lucie, et al.
Publicado: (2023)

Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies
por: Wilder, Brandon K., et al.
Publicado: (2022)

Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
por: de Camargo, Tarsila Mendes, et al.
Publicado: (2018)

Photoexcited Enzymes for Asymmetric Csp (3)−Csp (3) Cross‐Electrophile Couplings
por: Schmidt, Sandy
Publicado: (2022)

Beyond the ABCs—Discovery of Three New Plasmid Types in Rhodobacterales (RepQ, RepY, RepW)
por: Freese, Heike M., et al.
Publicado: (2022)

The efficacy of the prime-boost regimen for heterologous infectious bronchitis vaccines mandates the administration of homologous vaccines
por: Al-Kubati, Anwar A. G., et al.
Publicado: (2022)

Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages
por: Huang, Wei-Chiao, et al.
Publicado: (2022)

CSPα in neurodegenerative diseases
por: Huang, Liqin, et al.
Publicado: (2022)

Construction of congested Csp(3)–Csp(3) bonds by a formal Ni-catalyzed alkylboration
por: Simlandy, Amit Kumar, et al.
Publicado: (2021)

Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
por: Scally, Stephen W., et al.
Publicado: (2018)

Synthesis of aminyl biradicals by base-induced Csp(3)–Csp(3) coupling of cationic azo dyes
por: Liu, Yizhu, et al.
Publicado: (2019)

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
por: Kim, Young Chan, et al.
Publicado: (2020)

Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP)
por: Parums, Dinah V.
Publicado: (2021)

CSPα—chaperoning presynaptic proteins
por: Donnelier, Julien, et al.
Publicado: (2014)

Mastrevirus Rep and RepA Proteins Suppress de novo Transcriptional Gene Silencing
por: Watanabe, Kikyo, et al.
Publicado: (2021)

Cold shock CspA and CspB protein production during periodic temperature cycling in Escherichia coli
por: Ivancic, Tina, et al.
Publicado: (2013)

Stereoselective Csp(3)−Csp(2) Cross‐Couplings of Chiral Secondary Alkylzinc Reagents with Alkenyl and Aryl Halides
por: Skotnitzki, Juri, et al.
Publicado: (2019)

Organophotoredox/palladium dual catalytic decarboxylative Csp(3)–Csp(3) coupling of carboxylic acids and π-electrophiles
por: Cartwright, Kaitie C., et al.
Publicado: (2020)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
por: Bliss, Carly M., et al.
Publicado: (2018)

RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection
por: Enosse, Sonia, et al.
Publicado: (2006)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2022)

A Combination of Deworming and Prime-Boost Vaccination Regimen Restores Efficacy of Vaccination Against Influenza in Helminth-Infected Mice
por: Stetter, Nadine, et al.
Publicado: (2021)

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials
por: Brown, Scott A., et al.
Publicado: (2010)

DNA vaccines: prime time is now
por: Gary, Ebony N, et al.
Publicado: (2020)

Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
por: Sedegah, Martha, et al.
Publicado: (2011)

A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
por: Gimenez, Alba Marina, et al.
Publicado: (2021)

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
por: Ludwig, Julia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9tltcdhc3s91njs5s73hplubco